Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

The role of VEGF Expression in Superior Limbic Keratoconjunctivitis

sabrina bergeron; Pablo Zoroquiain; Jade Marie Lasiste; Jacqueline Coblentz; Debra-Meghan Sanft; Devinder Cheema; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1167. doi:

ARVO Annual Meeting Abstract June 2017

HER2 expression in retinoblastoma: a potential therapeutic target?

David Cordeiro Sousa; Pablo Zoroquiain; Evangelina Esposito; Maria Eugenia Orellana; Bruna Duarte Moron de Andrade; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1776. doi:

ARVO Annual Meeting Abstract June 2017

Metformin inhibits epithelial-to-mesenchymal transition in an in vitro model of posterior capsule opacification

Jade Lasiste; Denise Miyamoto; Pablo Zoroquiain; Sabrina Bergeron; Miguel N Burnier; Christina Mastromonaco

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3186. doi:

ARVO Annual Meeting Abstract June 2017

Clinicopathologic features of basal cell carcinoma of the eyelid with sebaceous differentiation

Taylor Nayman; Pablo Zoroquiain; Evangelina Esposito; Sabrina Bergeron; Carlos Augusto Moreira Neto; Sultan Aldrees; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3353. doi:

ARVO Annual Meeting Abstract June 2017

HER2 as a possible therapeutic target in squamous cell carcinoma of the conjunctiva

Evangelina Esposito; Pablo Zoroquiain; Ana Beatriz Toledo Dias; Flavio Luis Schneider; Sonia Corredor-Casas; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3354. doi:

ARVO Annual Meeting Abstract June 2017

Eyelid Sebaceous Carcinoma and HER2 expression

Alexandre Odashiro; Patricia Odashiro; Ana Beatriz Toledo Dias; Pablo Zoroquiain; Denise Miyamoto; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3361. doi:

ARVO Annual Meeting Abstract June 2017

Eyelid Sebaceous Carcinoma and Program cell death ligand 1 expression

Patricia Odashiro; Alexandre Odashiro; Ana Beatriz Toledo Dias; Pablo Zoroquiain; Denise Miyamoto; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3363. doi:

ARVO Annual Meeting Abstract June 2017

Characterization and prognostic significance and of small epithelioid cell populations in uveal melanoma

Pablo Zoroquiain; Jose Joao Mansure; Ciro Garcia; Maria Antonia Saornil; William April; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3954. doi:

ARVO Annual Meeting Abstract June 2017

Programmed cell death ligand 1 expression in uveal melanoma is associated with better patient outcome and decreased tumor infiltrating lymphocytes

Ana Beatriz Toledo Dias; Pablo Zoroquiain; Natalia Vila Grane; Ana Carolina Dias-Reis; Patrick T Logan; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4416. doi:

ARVO Annual Meeting Abstract September 2016

Immunohistochemical profile of keratoconic corneas

Marcelo Sobrinho; Sultan Aldrees; Pablo Zoroquiain; Patrick Logan; Ana Beatriz Toledo Dias; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4897. doi:

ARVO Annual Meeting Abstract September 2016

Programmed cell death ligand 1 expression in uveal melanoma is associated with better patient outcome

Pablo Zoroquiain; Ana Beatriz Toledo Dias; Patrick Logan; Sultan Aldrees; Evangelina Esposito; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5893. doi:

ARVO Annual Meeting Abstract September 2016

How to Automatically Grade posterior capsular opacification in post-mortem eyes

Matthew Balazsi; Sultan Aldrees; Pablo Zoroquiain; Christina Mastromonaco; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5937. doi:

ARVO Annual Meeting Abstract September 2016

Ocular clinical imaging and histopathological correlation: identifying the optimal fixation protocol

Carlos Augusto Moreira; Pablo Zoroquiain; Christina Mastromonaco; Evangelina Esposito; Jacqueline Coblentz; Andre C Romano; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):216. doi:

ARVO Annual Meeting Abstract September 2016

Evaluation of trabecular meshwork changes after cataract surgery using an automated advanced image analyzer

Ana Beatriz Toledo Dias; Pablo Zoroquiain; Nabil Saheb; Matthew Balazsi; Christina Mastromonaco; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1325. doi:

ARVO Annual Meeting Abstract September 2016

Evaluation of posterior capsular opacification using new automated detector opacification software(ADOS)

Christina Mastromonaco; Matthew Balazsi; Pablo Zoroquiain; Patrick Logan; Shawn C Maloney; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2015. doi:

ARVO Annual Meeting Abstract September 2016

Investigating Maspin Expression in Ocular Surface Squamous Neoplasia

Silvin Bakalian; Pablo Zoroquiain; Ana Beatriz Toledo Dias; Dina Abdulmannan; Patrick Logan; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2411. doi:

ARVO Annual Meeting Abstract September 2016

Assessment of the activity of different AU-011 doses in a xenograft uveal melanoma model

Patrick T Logan; Pablo Zoroquiain; Sultan Aldrees; Mohammed F. Qutub; Natalia Vila; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4111. doi:

ARVO Annual Meeting Abstract September 2016

GnRH Expression in Uveal Melanoma as a potential therapeutic target

Juliana Portela Passos; Pablo Zoroquiain; Joao Jose Mansure; Wael Almajed; Olavo Dias; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4115. doi:

ARVO Annual Meeting Abstract September 2016

The Effect of varying intensities of Blue Light on The Proliferation of Human Uveal Melanoma Cell-lines.

Sultan Aldrees; Pablo Zoroquiain; Patrick Logan; Vasco Bravo-Filho; Jacqueline Coblentz; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4119. doi:

ARVO Annual Meeting Abstract June 2015

Blue light filters prevent light-induced angiogenic factor secretion by retinal pigmented epithelial cells

Natalia Vila; Patrick T Logan; Vasco Bravo-Filho; Nathaniel Young; Pablo Zoroquiain; Miguel N Burnier; Henry C. Witelson Ocular Pathology Laboratory

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3386. doi:

1 2

Next 20 Results »

Advertisement